3D Printing of Mini Tablets for Pediatric Use.

Pharmaceuticals (Basel)

Department of Biopharmaceutics and Pharmaceutical Technology, Center of Drug Absorption and Transport, Institute of Pharmacy, University of Greifswald, Felix-Hausdorff-Str. 3, 17487 Greifswald, Germany.

Published: February 2021

In the treatment of pediatric diseases, suitable dosages and dosage forms are often not available for an adequate therapy. The use of innovative additive manufacturing techniques offers the possibility of producing pediatric dosage forms. In this study, the production of mini tablets using fused deposition modeling (FDM)-based 3D printing was investigated. Two pediatric drugs, caffeine and propranolol hydrochloride, were successfully processed into filaments using hyprolose and hypromellose as polymers. Subsequently, mini tablets with diameters between 1.5 and 4.0 mm were printed and characterized using optical and thermal analysis methods. By varying the number of mini tablets applied and by varying the diameter, we were able to achieve different release behaviors. This work highlights the potential value of FDM 3D printing for the on-demand production of patient individualized, small-scale batches of pediatric dosage forms.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916857PMC
http://dx.doi.org/10.3390/ph14020143DOI Listing

Publication Analysis

Top Keywords

mini tablets
16
dosage forms
12
pediatric dosage
8
pediatric
5
printing mini
4
tablets
4
tablets pediatric
4
pediatric treatment
4
treatment pediatric
4
pediatric diseases
4

Similar Publications

: In recent years, the integration of robotic systems into various aspects of daily life has become increasingly common. As these technologies continue to advance, ensuring user-friendly interfaces and seamless interactions becomes more essential. For social robots to genuinely provide lasting value to humans, a favourable user experience (UX) emerges as an essential prerequisite.

View Article and Find Full Text PDF

Terahertz (THz) pulsed imaging is a powerful tool for investigating solid dosage forms. However, traditional far-field systems struggle with physically small samples and strongly bent surfaces due to inherently limited lateral resolution. The present study introduces a novel approach using photo-conductive near-field microprobes (PC-NFMs) with a THz time-domain spectroscopy module to overcome the limitations of far-field setups concerning their achievable lateral resolution.

View Article and Find Full Text PDF

Deferiprone in Alzheimer Disease: A Randomized Clinical Trial.

JAMA Neurol

November 2024

The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia.

Importance: Interventions that substantially slow neurodegeneration are needed to address the growing burden of Alzheimer disease (AD) to societies worldwide. Elevated brain iron observed in AD has been associated with accelerated cognitive decline and may be a tractable drug target.

Objective: To investigate whether the brain-permeable iron chelator deferiprone slows cognitive decline in people with AD.

View Article and Find Full Text PDF

The control of ergot alkaloids in biotechnological processes is important in the context of obtaining new strain producers and studying the mechanisms of the biosynthesis, accumulation and secretion of alkaloids and the manufacturing of alkaloids. In pharmaceuticals, it is important to analyze the purity of raw materials, especially those capable of racemization, quality control of dosage forms and bulk drugs, stability during storage, etc. This review describes the methods used for qualitative and quantitative chemical analysis of ergot alkaloids in tablets and pharmaceutic forms, liquid cultural media and mycelia from submerged cultures of ergot and other organisms producing ergoalkaloid, sclerotias of industrial .

View Article and Find Full Text PDF

Cardiogenic shock (CS) is a devastating and fatal complication of acute myocardial infarction (AMI). CS can affect the pharmacokinetics and pharmacodynamics of medications. The unique properties of cangrelor make it the optimal P2Y12 inhibitor for CS-AMI, in terms of both efficacy and safety.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!